CLDN9 and hsa-miR-4496 as non-invasive biomarkers for gastric cancer detection
The results underscore the potential of CLDN9 and hsa-miR-4496 as promising non-invasive biomarkers for gastric cancer, with mitochondrial pathways being integral to their regulatory mechanisms. These biomarkers present potential for incorporation into clinical protocols, thereby facilitating early intervention and personalized treatment strategies for gastric cancer (GC).
Authors
- Qiongxia Hu (ORCID: https://orcid.org/0000-0002-7707-4732)
- Lu Han (ORCID: https://orcid.org/0000-0001-9524-884X)
- Fei Li (ORCID: https://orcid.org/0000-0001-8329-0899)
- Jinglin Wang (ORCID: https://orcid.org/0000-0002-4349-750X)
- Yue Shi (ORCID: https://orcid.org/0009-0001-6882-2209)
- Hong Pu (ORCID: https://orcid.org/0000-0002-9176-3585)
Institutions
- Guiyang Medical University (CN)
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
- Affiliated Hospital of Guizhou Medical University (CN)
- Guizhou Provincial People's Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-04-08
- DOI
- https://doi.org/10.1007/s12672-025-02153-7
- Citations
- 2
- Primary Topic
- MicroRNA in disease regulation
- Type
- article
- Field-Weighted Citation Impact
- 1.87